Quantcast
Mayo Clinic Task Force Challenges Some Recommendations In

Mayo Clinic Task Force Challenges Some Recommendations In Updated Cholesterol Treatment Guideline

Traci Klein, Mayo Clinic A Mayo Clinic task force challenges some recommendations in the updated guideline for cholesterol treatment unveiled by the American College of Cardiology (ACC) and American Heart Association (AHA) in 2013. The task...

Latest Hypercholesterolemia Stories

2014-08-12 12:29:20

LONDON, Aug. 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Hypercholesterolemia Market 2014-2018https://www.reportbuyer.com/product/2183843/Global-Hypercholesterolemia-Market-2014-2018.html About HypercholesterolemiaHypercholesterolemia is defined as a condition characterized by abnormally high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to cardiovascular diseases such as...

2014-07-24 11:35:43

American College of Cardiology Study underscores need to address risk factors such as diabetes, blood pressure, smoking While awareness campaigns may be getting women to go to the hospital more quickly during a heart-attack, a new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack. In the study published online today in the Journal of the American College of Cardiology, researchers from Yale School of...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-06-16 09:46:15

American Diabetes Association Panelists will argue pros and cons at symposium New guidelines for the treatment of high cholesterol are not appropriate for people with type 2 diabetes – or are they? Two researchers will debate the topic at a symposium to be held on Tuesday, June 17, at the American Diabetes Association's 74th Scientific Sessions®. At issue are the newest guidelines issued jointly by the American College of Cardiology and American Heart Association in November...

2014-05-29 08:28:37

Kurt Warner and wife, Brenda, motivate the 71 million Americans living with high cholesterol to win big by committing to heart health NEW YORK, May 29, 2014 /PRNewswire/ -- National heart-health initiative, First and Goal, today announced the launch of a consumer sweepstakes encouraging those living with high cholesterol and their support systems to join the First and Goal Team and pledge to prioritize heart health. The Campaign is a partnership with Kurt Warner, Super Bowl champion and...

2014-05-13 23:07:54

Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking statins, a cholesterol lowering medication. Cleveland, OH (PRWEB) May 13, 2014 Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking Lipitor, a cholesterol lowering medication. Lipitor, a brand name for the drug Atorvastatin that was approved by the FDA in...

2014-05-02 08:25:43

Data suggest lower risk of major adverse cardiovascular events and death, especially in patients with diabetes or prior coronary heart disease ORLANDO, Fla., May 2, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data suggesting that the use of a target low-density lipoprotein...

2014-05-01 08:34:19

Study results presented at the National Lipid Association Scientific Sessions 2014 ORLANDO, Fla., May 1, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. announced results of a pre-specified safety analysis from the INTREPID (HIV-infected patieNts and TREatment with PItavastatin vs. pravastatin for Dyslipidemia) trial evaluating the effect of LIVALO(®) (pitavastatin) 4 mg compared with pravastatin 40 mg in HIV-infected adults with dyslipidemia following completion of the 40-week...

2014-04-02 08:26:30

First and Goal Campaign encourages small, achievable accomplishments in cholesterol management NEW YORK, April 2, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. today announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize heart health. The campaign encourages the 71 million Americans living with high cholesterol to develop a personalized game plan to get...

2014-04-01 23:01:39

Susquehanna Health (SH) Cardiologist Dr. Liran Blum said new guidelines established by the American College of Cardiology (ACC) and American Heart Association (AHA) regarding the recommended use of cholesterol-reducing drugs called statins are appropriate and should be viewed primarily as guidelines when determining a patient’s course of treatment for the prevention of cardiovascular events such as heart attacks or strokes. “I think the guidelines and the recent [Duke University] study...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related